Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Gyre Therapeutics (GYRE) over the last 17 years, with Q3 2025 value amounting to $649000.0.

  • Gyre Therapeutics' Depreciation & Amortization (CF) rose 4584.27% to $649000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 6493.51%. This contributed to the annual value of $1.5 million for FY2024, which is 4422.72% up from last year.
  • Latest data reveals that Gyre Therapeutics reported Depreciation & Amortization (CF) of $649000.0 as of Q3 2025, which was up 4584.27% from $641000.0 recorded in Q2 2025.
  • Gyre Therapeutics' Depreciation & Amortization (CF)'s 5-year high stood at $867000.0 during Q4 2022, with a 5-year trough of $40000.0 in Q3 2022.
  • Over the past 5 years, Gyre Therapeutics' median Depreciation & Amortization (CF) value was $276000.0 (recorded in 2023), while the average stood at $306578.9.
  • As far as peak fluctuations go, Gyre Therapeutics' Depreciation & Amortization (CF) surged by 65391.3% in 2022, and later crashed by 6562.86% in 2023.
  • Quarter analysis of 5 years shows Gyre Therapeutics' Depreciation & Amortization (CF) stood at $115000.0 in 2021, then surged by 653.91% to $867000.0 in 2022, then tumbled by 65.63% to $298000.0 in 2023, then soared by 54.7% to $461000.0 in 2024, then soared by 40.78% to $649000.0 in 2025.
  • Its last three reported values are $649000.0 in Q3 2025, $641000.0 for Q2 2025, and $535000.0 during Q1 2025.